JP2022548145A5 - - Google Patents
Info
- Publication number
- JP2022548145A5 JP2022548145A5 JP2022517139A JP2022517139A JP2022548145A5 JP 2022548145 A5 JP2022548145 A5 JP 2022548145A5 JP 2022517139 A JP2022517139 A JP 2022517139A JP 2022517139 A JP2022517139 A JP 2022517139A JP 2022548145 A5 JP2022548145 A5 JP 2022548145A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- pharmaceutical composition
- domain
- cell
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025182211A JP2026021424A (ja) | 2019-09-16 | 2025-10-29 | 免疫療法の化合物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962901198P | 2019-09-16 | 2019-09-16 | |
| US62/901,198 | 2019-09-16 | ||
| PCT/US2020/050851 WO2021055342A1 (en) | 2019-09-16 | 2020-09-15 | Immunotherapy compounds and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025182211A Division JP2026021424A (ja) | 2019-09-16 | 2025-10-29 | 免疫療法の化合物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548145A JP2022548145A (ja) | 2022-11-16 |
| JP2022548145A5 true JP2022548145A5 (cg-RX-API-DMAC7.html) | 2023-09-21 |
| JP7773152B2 JP7773152B2 (ja) | 2025-11-19 |
Family
ID=74883667
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517139A Active JP7773152B2 (ja) | 2019-09-16 | 2020-09-15 | 免疫療法の化合物および方法 |
| JP2025182211A Pending JP2026021424A (ja) | 2019-09-16 | 2025-10-29 | 免疫療法の化合物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025182211A Pending JP2026021424A (ja) | 2019-09-16 | 2025-10-29 | 免疫療法の化合物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220324972A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4031565A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7773152B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220087441A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115023435B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020350524B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022004712A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3154158A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291343A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021055342A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200291130A1 (en) * | 2017-03-31 | 2020-09-17 | Merus N.V. | Antibodies for the treatment of erbb-2/erbb-3 positive tumors |
| CN118201961A (zh) * | 2021-09-16 | 2024-06-14 | Gt生物制药公司 | Pd-l1靶向融合蛋白及其使用方法 |
| WO2025136820A1 (en) * | 2023-12-18 | 2025-06-26 | Regents Of The University Of Minnesota | Poly-antigen cytokine-receptor complexes (paccs), compositions, and methods of use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104640561A (zh) * | 2012-07-23 | 2015-05-20 | 酵活有限公司 | 包含轻链和重链的选择性配对的免疫球蛋白构建体 |
| EP3066470A4 (en) * | 2013-11-05 | 2017-05-31 | Immunomedics, Inc. | Humanized anti-ceacam5 antibody and uses thereof |
| WO2015095412A1 (en) * | 2013-12-19 | 2015-06-25 | Zhong Wang | Bispecific antibody with two single-domain antigen-binding fragments |
| CA2953816C (en) * | 2014-06-30 | 2022-03-15 | Altor Bioscience Corporation | Il-15-based molecules and methods of use thereof |
| JP2018524373A (ja) * | 2015-07-15 | 2018-08-30 | ザイムワークス,インコーポレイテッド | 薬物がコンジュゲートされた二重特異性抗原結合コンストラクト |
| JP7461620B2 (ja) * | 2015-10-06 | 2024-04-04 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 治療用化合物及び方法 |
| US11291721B2 (en) * | 2016-03-21 | 2022-04-05 | Marengo Therapeutics, Inc. | Multispecific and multifunctional molecules and uses thereof |
| WO2019035938A1 (en) * | 2017-08-16 | 2019-02-21 | Elstar Therapeutics, Inc. | MULTISPECIFIC MOLECULES BINDING TO BCMA AND USES THEREOF |
-
2020
- 2020-09-15 BR BR112022004712A patent/BR112022004712A2/pt unknown
- 2020-09-15 WO PCT/US2020/050851 patent/WO2021055342A1/en not_active Ceased
- 2020-09-15 KR KR1020227012588A patent/KR20220087441A/ko active Pending
- 2020-09-15 EP EP20864423.7A patent/EP4031565A4/en active Pending
- 2020-09-15 CA CA3154158A patent/CA3154158A1/en active Pending
- 2020-09-15 US US17/641,594 patent/US20220324972A1/en active Pending
- 2020-09-15 CN CN202080079445.7A patent/CN115023435B/zh active Active
- 2020-09-15 AU AU2020350524A patent/AU2020350524B2/en active Active
- 2020-09-15 JP JP2022517139A patent/JP7773152B2/ja active Active
-
2022
- 2022-03-14 IL IL291343A patent/IL291343A/en unknown
-
2025
- 2025-10-29 JP JP2025182211A patent/JP2026021424A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022505158A5 (cg-RX-API-DMAC7.html) | ||
| US20230279101A1 (en) | Vegf/dll4 binding agents and uses thereof | |
| JP7308041B2 (ja) | 多重特異性抗原結合分子およびその使用 | |
| EP3319994B1 (en) | Multispecific antigen-binding molecules and uses thereof | |
| ES2719495T3 (es) | Anticuerpo dirigido contra b7-h6, proteínas de fusión, y métodos de uso de los mismos | |
| JP2026035673A (ja) | 抗her2抗体-薬物コンジュゲート投与による耐性癌の治療 | |
| Groner et al. | Therapeutic antibodies | |
| US20030157104A1 (en) | Treatment of refractory human tumors with epidermal growth factor receptor antagonists | |
| JP2020533311A5 (ja) | NKG2D、CD16およびNectin4に結合するタンパク質 | |
| US11407841B2 (en) | Recombinant bi-functional fusion protein and use thereof | |
| RU2018116565A (ru) | Терапевтические соединения и способы | |
| JP2010504755A5 (cg-RX-API-DMAC7.html) | ||
| CN104768579A (zh) | 使用Wnt途径结合剂来治疗神经内分泌肿瘤的方法 | |
| JP2023544143A5 (cg-RX-API-DMAC7.html) | ||
| JP2022534724A5 (cg-RX-API-DMAC7.html) | ||
| JP2025516703A5 (cg-RX-API-DMAC7.html) | ||
| CN103417965A (zh) | 一种含有抗vegf抗体的药物组合物 | |
| RU2021113936A (ru) | Вовлекающие nk молекулы и способы их применения | |
| KR101927732B1 (ko) | ErbB3에 특이적으로 결합하는 항체를 포함하는 항암제 내성 암의 예방 또는 치료용 약학적 조성물 및 이를 이용한 방법 | |
| US12428495B2 (en) | Antibodies against YKL-40 and uses thereof | |
| Guilleminault et al. | Monoclonal antibodies: An emerging class of therapeutics in non small cell lung cancer | |
| AU2017210673A1 (en) | VEGF/DLL4 binding agents and uses thereof | |
| Kiprijanov | Bispecific antibodies and immune therapy targeting | |
| TH1901000369A (th) | แอนติ-gprc5d แอนติบอดี, โมเลกุลที่ยึดเหนี่ยวแอนติเจนแบบมีสองความจำเพาะซึ่งยึดเหนี่ยวgprc5d และ cd3 และการใช้สิ่งดังกล่าว | |
| HK1255092A1 (en) | Multispecific antigen-binding molecules and uses thereof |